期刊文献+

多发性硬化中适应性免疫细胞的致病机制 被引量:5

The role of adaptive immune cells in multiple sclerosis
原文传递
导出
摘要 多发性硬化(multiple sclerosis, MS)是发生于中枢神经系统(central nervous system, CNS)的慢性进行性免疫炎性疾病,伴随少突胶质细胞、神经元和轴索的破坏。近年来研究发现,外周淋巴细胞(包括T细胞、B细胞及其亚群)在中枢神经系统的浸润作为MS的早期标志之一,在其发病和发展中起到重要作用,但其中许多细胞亚群的具体作用机制尚不明确。该综述通过总结最新研究结果,探讨外周适应性免疫细胞与中枢神经系统炎症关系以及不同种类适应性免疫细胞在MS中行使的功能。 Multiple sclerosis(MS) is a chronic progressive inflammatory disease with highly heterogeneous, chronic inflammatory and demyelinating perivascular lesions within the central nervous system(CNS). Recent studies have found that as one of the early signs of MS, the infiltration of the peripheral lymphocytes(including T cells, B cells and their subsets) in CNS plays an important role in the initiation and development of the disease. However, the specific function of these cells remains unclear. Here we give an overview on how peripheral adaptive immune cells present in CNS inflammation and summarize the latest researches of MS pathogenesis in order to understand how adaptive immune cells may contribute to the disease.
作者 孙一末 马三梅 SUN Yi-Mo;MA San-Mei(College of Life Science and Technology,Jinnan University,Guangzhou 510632,China)
出处 《生命科学》 CSCD 北大核心 2019年第1期27-34,共8页 Chinese Bulletin of Life Sciences
基金 广东省科技计划项目(2015B020202006)
关键词 多发性硬化 中枢神经系统 血脑屏障 适应性免疫细胞 multiple sclerosis central nervous system blood-brain barrier adaptive immune cells
  • 相关文献

参考文献3

二级参考文献103

  • 1Dutta R, Trapp BD.Pathogenesis of axonal and neuronal damage in multiple sclerosis[J]. Neurology, 2007, 68(22 Suppl 3):S22-S31.
  • 2Frohman EM, Racke MK, Raine CS. Multiple sclerosis- the plaque and its pathogenesis [J]. N Engl J Med, 2006, 354(9): 942-955.
  • 3Lassmann H, Bruck W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview [J]. Brain Pathol, 2007, 17(2): 210-218.
  • 4McFarland HF, Martin R. Multiple sclerosis: a complicated picture of autoimmunity[J]. Nat Immunol, 2007, 8(9): 913- 919.
  • 5Steinman L. A molecular trio in relapse and remission in multiple sclerosis[J]. Nat Rev Immunol, 2009, 9(6): 440-447.
  • 6Olsson T, Hillert J. The genetics of multiple sclerosis and its experimental models[J]. Curt Opin Neurol, 2008, 21(3): 255-260.
  • 7Sawcer S, Hellenthal G, Pirinen M, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis[J]. Nature, 2011, 476(7359): 214-219.
  • 8Fisher E, Lee JC, Nakamura K, et al. Gray matter atrophy in multiple sclerosis: a longitudinal study[J]. Ann Neurol, 2008, 64(3): 255-265.
  • 9Ontaneda D, Hyland M, Cohen JA. Multiple sclerosis: new insights in pathogenesis and novel therapeutics [J]. Annu Rev Med, 2012, 63: 389-404.
  • 10Bielekova B, Goodwin B, Richert N, et al. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase Ⅱ clinical trial with an altered peptide ligand[J]. Nat Med, 2000, 6(10): 1167-1175.

共引文献32

同被引文献74

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部